Effects of Food Intake Sequence on Substrate Utilisation and Endurance Performance

NCT07503990 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2026-06-10

No results posted yet for this study

Summary

The goal of this clinical trial is to understand how consuming a pre-exercise meal in different food intake sequences affects substrate utilisation and endurance exercise performance in healthy trained athletes. Specifically, the main questions it aims to answer are:

* Does consuming the pre-exercise meal in different food intake sequences alter the whole-body utilisation of fat and CHO at rest and during prolonged exercise at moderate to heavy intensities?
* Does consuming the pre-execise meal in different food intake sequences alter time-trial performance?
* Does consuming the pre-exercise meal in different food intake sequences alter other metabolic and physiological responses before, during or after exercise (i.e., blood glucose, blood lactate, heart rate (HR), ratings of perceived exertion (RPE), appetite)?

To address these questions, researchers will compare eating the dietary sources of rapidly absorbed CHO at the end (CHO-last meal pattern) or at the start (CHO-first meal pattern) of a standardised pre-exercise meal, in a randomised, counterbalanced, crossover design. Two hours after starting the pre-exercise meal, participants will perform a 60-min submaximal test on a cycling ergometer at two different intensities (30 min at 90% of the ventilatory threshold (VT) 1 and 30 min at 50% VT1-VT2), followed by a 10-km cycling time trial (TT).

In the screening visit participants will:

* Be screened for cardiometabolic conditions
* Perform an 8-12-min graded exercise test to determine their maximal pulmonary oxygen uptake (VO2max) and non-invasive submaximal anchors of performance (VT 1 and VT 2)
* Be familiarised to the experimental procedures

In experimental visits participants will:

* Follow guidelines pertaining to dietary intake, exercise and sleep in the previous 24 hours
* Have a standardised test meal in either the CHO-last or CHO-first food intake sequence
* Have 3 drops of capillary blood (0,9 µL in total) collected to measure glucose and lactate pre-meal, 15, 30, 45, 60, 90 and 120 min post-meal, every 15 min during submaximal exercise and post-TT
* Breathe into an indirect calorimetry mask for 5 min pre-meal, 15, 30, 45, 60, 90 and 120 min post-meal, every 15 min during submaximal exercise and post-TT
* Wear a HR monitor continuously during submaximal exercise and the TT
* Rate their appetite on visual analogue scales pre-meal, 15, 30, 45, 60, 90 and 120 min post-meal, and 30 min post-TT
* Rate their perceived exertion on RPE scales every 15 min during submaximal exercise, post-TT and 30 min post-TT.

Data will be compared within-participant between food intake sequences using linear mixed-effects models with random intercepts, to account for repeated measurements, interindividual variability, and potential missing data.

Conditions

  • Substrate Metabolism
  • Healthy Participants
  • Endurance Exercise

Interventions

OTHER

Carbohydrate-last meal pattern

Skyr yoghurt, whey protein and almonds over \~5 min, immediately followed by white bread, strawberry jam, banana and pulp-free orange juice over \~10 min.

OTHER

Carbohydrate-first meal pattern

White bread, strawberry jam, banana and pulp-free orange juice over \~10 min, immediately followed by skyr yoghurt, whey protein and almonds over \~5 min.

Sponsors & Collaborators

  • Portuguese Football Federation

    collaborator OTHER
  • Fundação para a Ciência e a Tecnologia

    collaborator OTHER
  • Universidade do Porto

    lead OTHER

Principal Investigators

  • Rita Giro · FCNAUP, University of Porto; Federação Portuguesa de Futebol

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2026-06-09
Completion
2026-06-09

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07503990 on ClinicalTrials.gov